| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | Wnt receptor activity | 1.03e-11 | 17 | 64 | 6 | GO:0042813 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.31e-10 | 11 | 64 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 5.65e-10 | 14 | 64 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 1.07e-09 | 34 | 64 | 6 | GO:0017147 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 5.64e-09 | 21 | 64 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.16e-07 | 37 | 64 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.32e-07 | 123 | 64 | 7 | GO:0030165 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.33e-07 | 38 | 64 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 2.21e-07 | 17 | 64 | 4 | GO:0004970 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.57e-07 | 46 | 64 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 9.72e-07 | 24 | 64 | 4 | GO:0099507 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.59e-06 | 27 | 64 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.74e-06 | 8 | 64 | 3 | GO:0022849 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 5.42e-06 | 79 | 64 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 5.85e-06 | 37 | 64 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 6.53e-06 | 38 | 64 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC9A5 KCNQ5 SLC28A2 GRIA1 GRIK3 GRIN2A GRIN2B SLC5A8 SLC9C2 | 1.65e-05 | 465 | 64 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLCO1B7 SLC44A1 SLC9A5 CLCN3 KCNQ5 SLC28A2 GRIA1 GRIK3 GRIN2A GRIN2B SLC5A8 SLC9C2 SLC14A2 NDUFC1 | 1.74e-05 | 1180 | 64 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.89e-05 | 102 | 64 | 5 | GO:0001540 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC9A5 CLCN3 KCNQ5 SLC28A2 GRIA1 GRIK3 GRIN2A GRIN2B SLC5A8 SLC9C2 NDUFC1 | 2.60e-05 | 758 | 64 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC9A5 KCNQ5 SLC28A2 GRIA1 GRIK3 GRIN2A GRIN2B SLC5A8 SLC9C2 NDUFC1 | 2.85e-05 | 627 | 64 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | cysteine-S-conjugate beta-lyase activity | 3.03e-05 | 3 | 64 | 2 | GO:0047804 | |
| GeneOntologyMolecularFunction | glycerol kinase activity | 3.03e-05 | 3 | 64 | 2 | GO:0004370 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.34e-05 | 57 | 64 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC9A5 CLCN3 KCNQ5 SLC28A2 GRIA1 GRIK3 GRIN2A GRIN2B SLC5A8 SLC9C2 NDUFC1 | 3.93e-05 | 793 | 64 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 4.09e-05 | 60 | 64 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 4.42e-05 | 296 | 64 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | transporter activity | SLCO1B7 SLC44A1 SLC9A5 CLCN3 KCNQ5 SLC28A2 GRIA1 GRIK3 GRIN2A GRIN2B SLC5A8 SLC9C2 SLC14A2 NDUFC1 | 4.61e-05 | 1289 | 64 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC9A5 KCNQ5 SLC28A2 GRIA1 GRIK3 GRIN2A GRIN2B SLC5A8 SLC9C2 NDUFC1 | 4.63e-05 | 664 | 64 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 5.25e-05 | 207 | 64 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 5.39e-05 | 208 | 64 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 5.61e-05 | 65 | 64 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 5.61e-05 | 65 | 64 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | kynurenine-oxoglutarate transaminase activity | 6.04e-05 | 4 | 64 | 2 | GO:0016212 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 6.04e-05 | 4 | 64 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 7.52e-05 | 136 | 64 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 7.52e-05 | 136 | 64 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 9.83e-05 | 75 | 64 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.09e-04 | 77 | 64 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.27e-04 | 152 | 64 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.32e-04 | 31 | 64 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.37e-04 | 477 | 64 | 8 | GO:0022804 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | JAK2 ERVK-6 ERBB4 GK GK2 ERVK-8 MAP3K11 ERVK-7 ERVK-10 ERVK-11 RSKR | 1.75e-04 | 938 | 64 | 11 | GO:0016772 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.91e-04 | 262 | 64 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 2.10e-04 | 7 | 64 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.20e-04 | 171 | 64 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 2.80e-04 | 8 | 64 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.99e-04 | 100 | 64 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.48e-04 | 293 | 64 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 3.60e-04 | 105 | 64 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 4.41e-04 | 430 | 64 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | zinc ion binding | ADH5 ERVK-6 CD4 ERVK-8 ERVK-7 GRIN2A GRIN2B ERVK-10 HERC2 ERVK-11 | 5.05e-04 | 891 | 64 | 10 | GO:0008270 |
| GeneOntologyMolecularFunction | gated channel activity | 6.94e-04 | 334 | 64 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 7.27e-04 | 337 | 64 | 6 | GO:0031625 | |
| GeneOntologyMolecularFunction | nuclease activity | 8.68e-04 | 231 | 64 | 5 | GO:0004518 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 8.98e-04 | 14 | 64 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | glutamate binding | 8.98e-04 | 14 | 64 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 9.95e-04 | 358 | 64 | 6 | GO:0044389 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.01e-03 | 138 | 64 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.06e-03 | 140 | 64 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | FZD1 FZD4 FZD7 FZD8 ERBB4 CD4 FZD5 GRIA1 GRIK3 GRIN2A GRIN2B FZD2 | 1.09e-03 | 1353 | 64 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | protein homodimerization activity | 1.11e-03 | 815 | 64 | 9 | GO:0042803 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 1.18e-03 | 16 | 64 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | carbon-sulfur lyase activity | 1.18e-03 | 16 | 64 | 2 | GO:0016846 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.44e-03 | 526 | 64 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.47e-03 | 70 | 64 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 1.67e-03 | 19 | 64 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.81e-03 | 875 | 64 | 9 | GO:0019904 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 2.03e-03 | 167 | 64 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 2.24e-03 | 81 | 64 | 3 | GO:0035254 | |
| GeneOntologyMolecularFunction | amide binding | 2.70e-03 | 299 | 64 | 5 | GO:0033218 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.77e-03 | 182 | 64 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 2.78e-03 | 301 | 64 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.88e-03 | 184 | 64 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | transaminase activity | 3.13e-03 | 26 | 64 | 2 | GO:0008483 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 3.32e-03 | 93 | 64 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 3.37e-03 | 27 | 64 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.42e-03 | 193 | 64 | 4 | GO:0015276 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.47e-03 | 459 | 64 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | peptide binding | 3.51e-03 | 318 | 64 | 5 | GO:0042277 | |
| GeneOntologyMolecularFunction | transferase activity, transferring nitrogenous groups | 3.62e-03 | 28 | 64 | 2 | GO:0016769 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 3.68e-03 | 197 | 64 | 4 | GO:0022834 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ADH5 ERVK-6 CD4 ERVK-8 ERVK-7 GRIN2A GRIN2B ERVK-10 HERC2 ERVK-11 | 4.33e-03 | 1189 | 64 | 10 | GO:0046914 |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 4.49e-03 | 337 | 64 | 5 | GO:0001664 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 4.76e-03 | 1205 | 64 | 10 | GO:0046983 | |
| GeneOntologyMolecularFunction | peptidase activity | 4.83e-03 | 654 | 64 | 7 | GO:0008233 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.84e-03 | 343 | 64 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 5.94e-03 | 36 | 64 | 2 | GO:0019865 | |
| GeneOntologyBiologicalProcess | DNA integration | 2.86e-10 | 13 | 63 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 1.27e-07 | 77 | 63 | 6 | GO:0035567 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.50e-07 | 48 | 63 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.32e-06 | 27 | 63 | 4 | GO:0035235 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 5.47e-06 | 83 | 63 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 6.65e-06 | 40 | 63 | 4 | GO:1990806 | |
| GeneOntologyBiologicalProcess | positive regulation of JUN kinase activity | 1.51e-05 | 49 | 63 | 4 | GO:0043507 | |
| GeneOntologyBiologicalProcess | glycerol-3-phosphate biosynthetic process | 2.75e-05 | 3 | 63 | 2 | GO:0046167 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 3.17e-05 | 59 | 63 | 4 | GO:0007215 | |
| GeneOntologyBiologicalProcess | glycerol metabolic process | 4.01e-05 | 22 | 63 | 3 | GO:0006071 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 5.19e-05 | 132 | 63 | 5 | GO:0035249 | |
| GeneOntologyBiologicalProcess | regulation of JUN kinase activity | 5.24e-05 | 67 | 63 | 4 | GO:0043506 | |
| GeneOntologyBiologicalProcess | L-kynurenine catabolic process | 5.49e-05 | 4 | 63 | 2 | GO:0097053 | |
| GeneOntologyBiologicalProcess | alditol metabolic process | 6.72e-05 | 26 | 63 | 3 | GO:0019400 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 1.26e-04 | 32 | 63 | 3 | GO:0099505 | |
| GeneOntologyBiologicalProcess | muscular septum morphogenesis | 1.37e-04 | 6 | 63 | 2 | GO:0003150 | |
| GeneOntologyBiologicalProcess | glycerol catabolic process | 1.37e-04 | 6 | 63 | 2 | GO:0019563 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, calcium modulating pathway | 1.91e-04 | 7 | 63 | 2 | GO:0007223 | |
| GeneOntologyBiologicalProcess | L-kynurenine metabolic process | 1.91e-04 | 7 | 63 | 2 | GO:0097052 | |
| GeneOntologyBiologicalProcess | alditol catabolic process | 1.91e-04 | 7 | 63 | 2 | GO:0019405 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 2.12e-04 | 178 | 63 | 5 | GO:0006261 | |
| GeneOntologyBiologicalProcess | synapse organization | 2.22e-04 | 685 | 63 | 9 | GO:0050808 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 2.29e-04 | 405 | 63 | 7 | GO:0033674 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | FZD4 JAK2 FZD8 ERBB4 CD4 FZD5 APAF1 MAP3K11 GRIN2A GRIN2B SNX13 | 2.54e-04 | 1028 | 63 | 11 | GO:0043085 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | FZD1 FZD4 JAK2 FZD8 ERBB4 CD4 FZD5 APAF1 MAP3K11 GRIN2A GRIN2B FZD2 SNX13 | 3.24e-04 | 1430 | 63 | 13 | GO:0044093 |
| GeneOntologyBiologicalProcess | establishment of planar polarity | 3.29e-04 | 44 | 63 | 3 | GO:0001736 | |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | 3.33e-04 | 571 | 63 | 8 | GO:0043410 | |
| GeneOntologyBiologicalProcess | establishment of tissue polarity | 3.52e-04 | 45 | 63 | 3 | GO:0007164 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 4.00e-04 | 47 | 63 | 3 | GO:0046164 | |
| GeneOntologyBiologicalProcess | membranous septum morphogenesis | 4.07e-04 | 10 | 63 | 2 | GO:0003149 | |
| GeneOntologyBiologicalProcess | positive regulation of inhibitory postsynaptic potential | 4.07e-04 | 10 | 63 | 2 | GO:0097151 | |
| GeneOntologyBiologicalProcess | hard palate development | 4.07e-04 | 10 | 63 | 2 | GO:0060022 | |
| GeneOntologyBiologicalProcess | glycerol-3-phosphate metabolic process | 4.07e-04 | 10 | 63 | 2 | GO:0006072 | |
| GeneOntologyBiologicalProcess | response to granulocyte macrophage colony-stimulating factor | 4.96e-04 | 11 | 63 | 2 | GO:0097012 | |
| GeneOntologyBiologicalProcess | kynurenine metabolic process | 4.96e-04 | 11 | 63 | 2 | GO:0070189 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 5.38e-04 | 218 | 63 | 5 | GO:0071897 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 5.73e-04 | 780 | 63 | 9 | GO:0042327 | |
| GeneOntologyBiologicalProcess | alditol phosphate metabolic process | 5.94e-04 | 12 | 63 | 2 | GO:0052646 | |
| GeneOntologyBiologicalProcess | modulation of inhibitory postsynaptic potential | 5.94e-04 | 12 | 63 | 2 | GO:0098828 | |
| GeneOntologyBiologicalProcess | polyol catabolic process | 5.94e-04 | 12 | 63 | 2 | GO:0046174 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 6.29e-04 | 344 | 63 | 6 | GO:0060070 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 6.36e-04 | 55 | 63 | 3 | GO:0060071 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 6.54e-04 | 129 | 63 | 4 | GO:0043406 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | 6.89e-04 | 350 | 63 | 6 | GO:0045860 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 6.93e-04 | 131 | 63 | 4 | GO:0030510 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic cytosolic calcium ion concentration | 7.01e-04 | 13 | 63 | 2 | GO:0099566 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 7.18e-04 | 490 | 63 | 7 | GO:0051347 | |
| GeneOntologyBiologicalProcess | organophosphate biosynthetic process | 7.37e-04 | 644 | 63 | 8 | GO:0090407 | |
| GeneOntologyBiologicalProcess | response to amine | 7.43e-04 | 58 | 63 | 3 | GO:0014075 | |
| GeneOntologyBiologicalProcess | regulation of MAPK cascade | 7.84e-04 | 815 | 63 | 9 | GO:0043408 | |
| GeneOntologyBiologicalProcess | regulation of establishment of planar polarity involved in neural tube closure | 9.40e-04 | 15 | 63 | 2 | GO:0090178 | |
| GeneOntologyBiologicalProcess | excitatory chemical synaptic transmission | 1.07e-03 | 16 | 63 | 2 | GO:0098976 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity involved in neural tube closure | 1.07e-03 | 16 | 63 | 2 | GO:0090177 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | FZD1 FZD4 FZD7 JAK2 FZD8 ERBB4 CD4 FZD5 MAP3K11 FKBP8 KIRREL2 | 1.11e-03 | 1226 | 63 | 11 | GO:0042325 |
| GeneOntologyBiologicalProcess | brain development | 1.14e-03 | 859 | 63 | 9 | GO:0007420 | |
| GeneOntologyBiologicalProcess | positive regulation of cysteine-type endopeptidase activity | 1.20e-03 | 152 | 63 | 4 | GO:2001056 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | 1.33e-03 | 879 | 63 | 9 | GO:0045937 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | 1.33e-03 | 879 | 63 | 9 | GO:0010562 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity of embryonic epithelium | 1.36e-03 | 18 | 63 | 2 | GO:0042249 | |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 1.45e-03 | 73 | 63 | 3 | GO:0001738 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 1.45e-03 | 73 | 63 | 3 | GO:1901616 | |
| GeneOntologyBiologicalProcess | response to ethanol | 1.49e-03 | 161 | 63 | 4 | GO:0045471 | |
| GeneOntologyBiologicalProcess | regulation of establishment of planar polarity | 1.52e-03 | 19 | 63 | 2 | GO:0090175 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | 1.56e-03 | 724 | 63 | 8 | GO:0001934 | |
| GeneOntologyBiologicalProcess | head development | 1.81e-03 | 919 | 63 | 9 | GO:0060322 | |
| GeneOntologyCellularComponent | vesicle membrane | FZD4 FZD7 CHMP7 CD4 SLC9A5 CLCN3 PLA1A FZD5 SLC28A2 GRIA1 TSPAN14 SLC35G2 SCAMP3 GRIN2A GRIN2B FZD2 SNX13 | 2.42e-07 | 1325 | 63 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | FZD4 FZD7 CHMP7 CD4 SLC9A5 CLCN3 PLA1A FZD5 GRIA1 TSPAN14 SLC35G2 SCAMP3 GRIN2A GRIN2B FZD2 SNX13 | 1.11e-06 | 1307 | 63 | 16 | GO:0030659 |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.02e-05 | 45 | 63 | 4 | GO:0008328 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 1.55e-05 | 50 | 63 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.95e-05 | 277 | 63 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.21e-05 | 112 | 63 | 5 | GO:0055038 | |
| GeneOntologyCellularComponent | synaptic membrane | 5.94e-05 | 583 | 63 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 9.50e-05 | 79 | 63 | 4 | GO:0030669 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.11e-04 | 157 | 63 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 1.54e-04 | 817 | 63 | 10 | GO:0098978 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 2.12e-04 | 405 | 63 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 2.46e-04 | 101 | 63 | 4 | GO:0045334 | |
| GeneOntologyCellularComponent | mitochondrial membrane | 2.46e-04 | 866 | 63 | 10 | GO:0031966 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 3.17e-04 | 9 | 63 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.50e-04 | 201 | 63 | 5 | GO:0099634 | |
| GeneOntologyCellularComponent | mitochondrial envelope | 3.72e-04 | 912 | 63 | 10 | GO:0005740 | |
| GeneOntologyCellularComponent | axon terminus | 4.27e-04 | 210 | 63 | 5 | GO:0043679 | |
| GeneOntologyCellularComponent | endosome membrane | 4.34e-04 | 602 | 63 | 8 | GO:0010008 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 4.35e-04 | 49 | 63 | 3 | GO:0099092 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 4.46e-04 | 212 | 63 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 4.76e-04 | 215 | 63 | 5 | GO:0030662 | |
| GeneOntologyCellularComponent | recycling endosome | 5.50e-04 | 222 | 63 | 5 | GO:0055037 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 6.42e-04 | 350 | 63 | 6 | GO:0098802 | |
| GeneOntologyCellularComponent | dendrite membrane | 6.45e-04 | 56 | 63 | 3 | GO:0032590 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 6.45e-04 | 56 | 63 | 3 | GO:0099091 | |
| GeneOntologyCellularComponent | endosome | FZD7 JAK2 CHMP7 CD4 SLC9A5 CLCN3 FZD5 GRIA1 SCAMP3 GRIN2B SNX13 | 6.63e-04 | 1167 | 63 | 11 | GO:0005768 |
| GeneOntologyCellularComponent | neuron projection terminus | 6.85e-04 | 233 | 63 | 5 | GO:0044306 | |
| GeneOntologyCellularComponent | coated vesicle | 7.44e-04 | 360 | 63 | 6 | GO:0030135 | |
| GeneOntologyCellularComponent | mitochondrial outer membrane | 7.97e-04 | 241 | 63 | 5 | GO:0005741 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 1.01e-03 | 147 | 63 | 4 | GO:0030665 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.04e-03 | 384 | 63 | 6 | GO:0030139 | |
| GeneOntologyCellularComponent | organelle envelope | CHMP7 SLC44A1 GK GK2 SPART LMNB2 FKBP8 HERC2 COQ2 NDUFC1 MFN1 GNPAT | 1.06e-03 | 1435 | 63 | 12 | GO:0031967 |
| GeneOntologyCellularComponent | presynapse | 1.28e-03 | 886 | 63 | 9 | GO:0098793 | |
| GeneOntologyCellularComponent | dendritic spine membrane | 1.33e-03 | 18 | 63 | 2 | GO:0032591 | |
| GeneOntologyCellularComponent | axon | 1.34e-03 | 891 | 63 | 9 | GO:0030424 | |
| GeneOntologyCellularComponent | organelle outer membrane | 1.53e-03 | 279 | 63 | 5 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 1.58e-03 | 281 | 63 | 5 | GO:0019867 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.69e-03 | 78 | 63 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | receptor complex | 1.78e-03 | 581 | 63 | 7 | GO:0043235 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.87e-03 | 431 | 63 | 6 | GO:0031253 | |
| GeneOntologyCellularComponent | neuron projection membrane | 1.95e-03 | 82 | 63 | 3 | GO:0032589 | |
| GeneOntologyCellularComponent | distal axon | 1.96e-03 | 435 | 63 | 6 | GO:0150034 | |
| GeneOntologyCellularComponent | synaptic vesicle | 2.10e-03 | 300 | 63 | 5 | GO:0008021 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.38e-03 | 785 | 63 | 8 | GO:0098797 | |
| GeneOntologyCellularComponent | exocytic vesicle | 2.77e-03 | 320 | 63 | 5 | GO:0070382 | |
| GeneOntologyCellularComponent | terminal bouton | 3.05e-03 | 96 | 63 | 3 | GO:0043195 | |
| GeneOntologyCellularComponent | leading edge membrane | 3.71e-03 | 210 | 63 | 4 | GO:0031256 | |
| GeneOntologyCellularComponent | early endosome membrane | 3.84e-03 | 212 | 63 | 4 | GO:0031901 | |
| GeneOntologyCellularComponent | inhibitory synapse | 3.93e-03 | 31 | 63 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | dendrite | 4.10e-03 | 858 | 63 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | excitatory synapse | 4.14e-03 | 107 | 63 | 3 | GO:0060076 | |
| GeneOntologyCellularComponent | dendritic tree | 4.15e-03 | 860 | 63 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | transport vesicle | 4.67e-03 | 519 | 63 | 6 | GO:0030133 | |
| GeneOntologyCellularComponent | membrane protein complex | JAK2 FZD8 CHMP7 CD4 KCNQ5 GRIA1 GRIK3 GRIN2A GRIN2B NDUFC1 MFN1 | 4.79e-03 | 1498 | 63 | 11 | GO:0098796 |
| GeneOntologyCellularComponent | transmembrane transporter complex | 4.85e-03 | 523 | 63 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 5.61e-03 | 378 | 63 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 5.69e-03 | 237 | 63 | 4 | GO:0030136 | |
| GeneOntologyCellularComponent | cell surface | 5.84e-03 | 1111 | 63 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | dendritic spine | 6.12e-03 | 242 | 63 | 4 | GO:0043197 | |
| GeneOntologyCellularComponent | transporter complex | 6.17e-03 | 550 | 63 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | neuron spine | 6.57e-03 | 247 | 63 | 4 | GO:0044309 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 7.46e-03 | 43 | 63 | 2 | GO:0098688 | |
| GeneOntologyCellularComponent | anchoring junction | 8.73e-03 | 976 | 63 | 8 | GO:0070161 | |
| GeneOntologyCellularComponent | presynaptic active zone | 8.88e-03 | 141 | 63 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 1.09e-02 | 1228 | 63 | 9 | GO:0036477 | |
| GeneOntologyCellularComponent | postsynapse | 1.11e-02 | 1018 | 63 | 8 | GO:0098794 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.15e-02 | 451 | 63 | 5 | GO:0014069 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 1.18e-02 | 293 | 63 | 4 | GO:0030658 | |
| GeneOntologyCellularComponent | secretory vesicle | 1.20e-02 | 1246 | 63 | 9 | GO:0099503 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.44e-02 | 477 | 63 | 5 | GO:0032279 | |
| GeneOntologyCellularComponent | early endosome | 1.49e-02 | 481 | 63 | 5 | GO:0005769 | |
| Domain | Frizzled | 3.49e-13 | 11 | 59 | 6 | IPR000539 | |
| Domain | Frizzled | 3.49e-13 | 11 | 59 | 6 | PF01534 | |
| Domain | Frizzled | 3.49e-13 | 11 | 59 | 6 | SM01330 | |
| Domain | Frizzled/SFRP | 5.98e-12 | 16 | 59 | 6 | IPR015526 | |
| Domain | FRI | 2.87e-11 | 20 | 59 | 6 | SM00063 | |
| Domain | - | 4.00e-11 | 21 | 59 | 6 | 1.10.2000.10 | |
| Domain | Frizzled_dom | 9.85e-11 | 24 | 59 | 6 | IPR020067 | |
| Domain | FZ | 9.85e-11 | 24 | 59 | 6 | PS50038 | |
| Domain | Fz | 9.85e-11 | 24 | 59 | 6 | PF01392 | |
| Domain | GPCR_2-like | 3.36e-08 | 60 | 59 | 6 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 3.71e-08 | 61 | 59 | 6 | PS50261 | |
| Domain | Iontro_rcpt | 2.66e-07 | 18 | 59 | 4 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 2.66e-07 | 18 | 59 | 4 | PF10613 | |
| Domain | Iono_rcpt_met | 2.66e-07 | 18 | 59 | 4 | IPR001508 | |
| Domain | Glu/Gly-bd | 2.66e-07 | 18 | 59 | 4 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 2.66e-07 | 18 | 59 | 4 | SM00918 | |
| Domain | Lig_chan | 2.66e-07 | 18 | 59 | 4 | PF00060 | |
| Domain | PBPe | 2.66e-07 | 18 | 59 | 4 | SM00079 | |
| Domain | GPCR_2_secretin-like | 1.27e-06 | 60 | 59 | 5 | IPR000832 | |
| Domain | ANF_lig-bd_rcpt | 5.49e-06 | 37 | 59 | 4 | IPR001828 | |
| Domain | ANF_receptor | 5.49e-06 | 37 | 59 | 4 | PF01094 | |
| Domain | Peripla_BP_I | 6.80e-06 | 39 | 59 | 4 | IPR028082 | |
| Domain | NMDAR2_C | 2.94e-05 | 3 | 59 | 2 | PF10565 | |
| Domain | Carb_kinase_FGGY_CS | 2.94e-05 | 3 | 59 | 2 | IPR018483 | |
| Domain | NMDAR2_C | 2.94e-05 | 3 | 59 | 2 | IPR018884 | |
| Domain | Glycerol_kin | 5.86e-05 | 4 | 59 | 2 | IPR005999 | |
| Domain | FGGY_KINASES_2 | 9.75e-05 | 5 | 59 | 2 | PS00445 | |
| Domain | FGGY_KINASES_1 | 9.75e-05 | 5 | 59 | 2 | PS00933 | |
| Domain | Carb_kinase_FGGY_C | 9.75e-05 | 5 | 59 | 2 | IPR018485 | |
| Domain | FGGY_C | 1.46e-04 | 6 | 59 | 2 | PF02782 | |
| Domain | Carb_kinase_FGGY_N | 1.46e-04 | 6 | 59 | 2 | IPR018484 | |
| Domain | Carb_kinase_FGGY | 2.04e-04 | 7 | 59 | 2 | IPR000577 | |
| Domain | FGGY_N | 2.04e-04 | 7 | 59 | 2 | PF00370 | |
| Domain | Cation/H_exchanger_CPA1 | 5.30e-04 | 11 | 59 | 2 | IPR018422 | |
| Domain | Na_H_Exchanger | 8.71e-04 | 14 | 59 | 2 | PF00999 | |
| Domain | EamA_dom | 8.71e-04 | 14 | 59 | 2 | IPR000620 | |
| Domain | Cation/H_exchanger | 8.71e-04 | 14 | 59 | 2 | IPR006153 | |
| Domain | EamA | 8.71e-04 | 14 | 59 | 2 | PF00892 | |
| Domain | Aminotransferase_I/II | 1.29e-03 | 17 | 59 | 2 | IPR004839 | |
| Domain | Aminotran_1_2 | 1.29e-03 | 17 | 59 | 2 | PF00155 | |
| Domain | Tetraspanin_CS | 1.98e-03 | 21 | 59 | 2 | IPR018503 | |
| Domain | TyrKc | 2.72e-03 | 88 | 59 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 2.72e-03 | 88 | 59 | 3 | IPR020635 | |
| Domain | TM4_1 | 3.04e-03 | 26 | 59 | 2 | PS00421 | |
| Domain | TRYPSIN_HIS | 4.23e-03 | 103 | 59 | 3 | IPR018114 | |
| Domain | Tetraspanin | 4.58e-03 | 32 | 59 | 2 | IPR000301 | |
| Domain | Tetraspanin_EC2 | 4.58e-03 | 32 | 59 | 2 | IPR008952 | |
| Domain | TRYPSIN_HIS | 4.71e-03 | 107 | 59 | 3 | PS00134 | |
| Domain | Tetraspannin | 4.86e-03 | 33 | 59 | 2 | PF00335 | |
| Domain | Tetraspanin/Peripherin | 4.86e-03 | 33 | 59 | 2 | IPR018499 | |
| Domain | - | 5.46e-03 | 35 | 59 | 2 | 3.90.1150.10 | |
| Domain | Peptidase_S1A | 5.48e-03 | 113 | 59 | 3 | IPR001314 | |
| Domain | TRYPSIN_DOM | 5.75e-03 | 115 | 59 | 3 | PS50240 | |
| Domain | PyrdxlP-dep_Trfase_major_sub2 | 5.77e-03 | 36 | 59 | 2 | IPR015422 | |
| Domain | Tryp_SPc | 6.04e-03 | 117 | 59 | 3 | SM00020 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 2.90e-12 | 14 | 47 | 6 | M47834 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 7.70e-12 | 16 | 47 | 6 | M47823 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO | 2.59e-11 | 19 | 47 | 6 | M47833 | |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 4.06e-11 | 66 | 47 | 8 | M39642 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 3.52e-10 | 28 | 47 | 6 | M77 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.78e-09 | 36 | 47 | 6 | M39699 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 6.33e-09 | 44 | 47 | 6 | MM15878 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 7.29e-09 | 45 | 47 | 6 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 8.36e-09 | 46 | 47 | 6 | M47409 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 2.53e-08 | 55 | 47 | 6 | M17807 | |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 4.31e-08 | 60 | 47 | 6 | MM15150 | |
| Pathway | REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS | 6.40e-08 | 64 | 47 | 6 | M27396 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 3.54e-07 | 85 | 47 | 6 | MM15041 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 3.54e-07 | 85 | 47 | 6 | M48315 | |
| Pathway | WNT_SIGNALING | 4.66e-07 | 89 | 47 | 6 | M5493 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 5.67e-07 | 92 | 47 | 6 | M27322 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 6.44e-07 | 94 | 47 | 6 | M797 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 9.17e-07 | 23 | 47 | 4 | M27949 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 9.86e-07 | 101 | 47 | 6 | M39387 | |
| Pathway | KEGG_MELANOGENESIS | 9.86e-07 | 101 | 47 | 6 | M7761 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 9.86e-07 | 101 | 47 | 6 | MM15829 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 1.63e-06 | 110 | 47 | 6 | MM15977 | |
| Pathway | WP_WNT_SIGNALING | 1.71e-06 | 61 | 47 | 5 | MM15893 | |
| Pathway | REACTOME_SIGNALING_BY_RNF43_MUTANTS | 1.92e-06 | 8 | 47 | 3 | M27433 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 2.09e-06 | 261 | 47 | 8 | M42565 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 2.22e-06 | 116 | 47 | 6 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 2.34e-06 | 117 | 47 | 6 | M39530 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 2.46e-06 | 118 | 47 | 6 | M39852 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 3.13e-06 | 123 | 47 | 6 | MM14988 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 8.43e-06 | 146 | 47 | 6 | M27288 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.02e-05 | 151 | 47 | 6 | M19428 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 1.08e-05 | 326 | 47 | 8 | M39379 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 1.11e-05 | 89 | 47 | 5 | M39563 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.47e-05 | 161 | 47 | 6 | M39770 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 1.78e-05 | 98 | 47 | 5 | M39731 | |
| Pathway | WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS | 2.29e-05 | 17 | 47 | 3 | M39525 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 2.74e-05 | 18 | 47 | 3 | M48098 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 2.74e-05 | 18 | 47 | 3 | M47761 | |
| Pathway | KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS | 2.82e-05 | 53 | 47 | 4 | M3812 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 3.24e-05 | 19 | 47 | 3 | M47677 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 3.55e-05 | 113 | 47 | 5 | M39669 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 3.81e-05 | 20 | 47 | 3 | MM15155 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 4.43e-05 | 21 | 47 | 3 | M27736 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 4.43e-05 | 21 | 47 | 3 | M838 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 4.43e-05 | 21 | 47 | 3 | M27401 | |
| Pathway | WP_TRIACYLGLYCERIDE_SYNTHESIS | 5.87e-05 | 23 | 47 | 3 | MM15890 | |
| Pathway | WP_TRIACYLGLYCERIDE_SYNTHESIS | 6.69e-05 | 24 | 47 | 3 | M39692 | |
| Pathway | PID_REELIN_PATHWAY | 1.07e-04 | 28 | 47 | 3 | M69 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 1.08e-04 | 5 | 47 | 2 | M47667 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.31e-04 | 238 | 47 | 6 | MM15076 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.34e-04 | 239 | 47 | 6 | MM14756 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.46e-04 | 31 | 47 | 3 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.46e-04 | 31 | 47 | 3 | MM15154 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.54e-04 | 154 | 47 | 5 | M39739 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 1.61e-04 | 32 | 47 | 3 | M23 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 1.62e-04 | 6 | 47 | 2 | M47668 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.74e-04 | 158 | 47 | 5 | MM14791 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 1.93e-04 | 34 | 47 | 3 | M27405 | |
| Pathway | WP_GPCRS_NONODORANT | 2.39e-04 | 266 | 47 | 6 | MM15843 | |
| Pathway | WP_CANCER_PATHWAYS | 2.42e-04 | 507 | 47 | 8 | M48302 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.66e-04 | 94 | 47 | 4 | M2843 | |
| Pathway | PID_ERBB4_PATHWAY | 2.70e-04 | 38 | 47 | 3 | M13 | |
| Pathway | WP_GPCRS_OTHER | 2.88e-04 | 96 | 47 | 4 | MM15939 | |
| Pathway | REACTOME_CA2_PATHWAY | 4.47e-04 | 45 | 47 | 3 | MM15040 | |
| Pathway | REACTOME_UPTAKE_OF_DIETARY_COBALAMINS_INTO_ENTEROCYTES | 4.81e-04 | 10 | 47 | 2 | M45024 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 5.78e-04 | 205 | 47 | 5 | M752 | |
| Pathway | WP_IDO_METABOLIC_PATHWAY | 5.87e-04 | 11 | 47 | 2 | M48109 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 6.94e-04 | 325 | 47 | 6 | M12868 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 | 7.03e-04 | 12 | 47 | 2 | MM15163 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 7.03e-04 | 12 | 47 | 2 | MM15447 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 7.52e-04 | 330 | 47 | 6 | M7847 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 8.07e-04 | 55 | 47 | 3 | M39763 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 | 8.29e-04 | 13 | 47 | 2 | M27415 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 9.65e-04 | 14 | 47 | 2 | M619 | |
| Pathway | REACTOME_TRYPTOPHAN_CATABOLISM | 9.65e-04 | 14 | 47 | 2 | M1084 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.03e-03 | 233 | 47 | 5 | M27099 | |
| Pathway | BIOCARTA_NO2IL12_PATHWAY | 1.11e-03 | 15 | 47 | 2 | M6231 | |
| Pathway | BIOCARTA_NO2IL12_PATHWAY | 1.11e-03 | 15 | 47 | 2 | MM1446 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 1.11e-03 | 15 | 47 | 2 | M47691 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.14e-03 | 62 | 47 | 3 | M27321 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 1.19e-03 | 140 | 47 | 4 | M42572 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 1.30e-03 | 367 | 47 | 6 | M48346 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.38e-03 | 249 | 47 | 5 | M5988 | |
| Pathway | REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS | 1.61e-03 | 18 | 47 | 2 | M27901 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.63e-03 | 70 | 47 | 3 | M3115 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 1.66e-03 | 153 | 47 | 4 | M39546 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.91e-03 | 74 | 47 | 3 | MM15962 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.97e-03 | 270 | 47 | 5 | M15514 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.99e-03 | 20 | 47 | 2 | MM1445 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.99e-03 | 20 | 47 | 2 | MM15485 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 2.19e-03 | 21 | 47 | 2 | M11650 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 2.19e-03 | 21 | 47 | 2 | M27944 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 2.23e-03 | 166 | 47 | 4 | M16024 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.31e-03 | 411 | 47 | 6 | M735 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 2.41e-03 | 22 | 47 | 2 | MM15104 | |
| Pathway | REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM | 2.41e-03 | 22 | 47 | 2 | M27084 | |
| Pathway | BIOCARTA_CASPASE_PATHWAY | 2.41e-03 | 22 | 47 | 2 | M17902 | |
| Pathway | REACTOME_TRIGLYCERIDE_METABOLISM | 2.63e-03 | 23 | 47 | 2 | MM15575 | |
| Pathway | WP_MTHFR_DEFICIENCY | 2.87e-03 | 24 | 47 | 2 | M39755 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.03e-03 | 87 | 47 | 3 | M27617 | |
| Pubmed | Expression of Frizzled genes in developing and postnatal hair follicles. | 7.02e-15 | 10 | 65 | 6 | 15245425 | |
| Pubmed | Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis. | 7.02e-15 | 10 | 65 | 6 | 17532316 | |
| Pubmed | Frizzled-9 impairs acetylcholine receptor clustering in skeletal muscle cells. | 1.54e-14 | 11 | 65 | 6 | 24860427 | |
| Pubmed | Molecular determinants of WNT9b responsiveness in nephron progenitor cells. | 1.54e-14 | 11 | 65 | 6 | 30978219 | |
| Pubmed | 1.54e-14 | 11 | 65 | 6 | 17582687 | ||
| Pubmed | 1.54e-14 | 11 | 65 | 6 | 17576136 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 15370539 | ||
| Pubmed | Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families. | 4.09e-13 | 17 | 65 | 6 | 28733458 | |
| Pubmed | Differential expression of the Wnt putative receptors Frizzled during mouse somitogenesis. | 1.09e-12 | 8 | 65 | 5 | 10559494 | |
| Pubmed | A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals. | 2.44e-12 | 9 | 65 | 5 | 9707618 | |
| Pubmed | 2.45e-12 | 22 | 65 | 6 | 17064353 | ||
| Pubmed | A role for Wnt/beta-catenin signaling in lens epithelial differentiation. | 5.79e-12 | 25 | 65 | 6 | 12812787 | |
| Pubmed | 1.54e-11 | 29 | 65 | 6 | 18364260 | ||
| Pubmed | 6.27e-11 | 36 | 65 | 6 | 24151333 | ||
| Pubmed | 7.47e-11 | 37 | 65 | 6 | 15342465 | ||
| Pubmed | Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis. | 7.47e-11 | 37 | 65 | 6 | 18800919 | |
| Pubmed | Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals. | 8.86e-11 | 38 | 65 | 6 | 21041481 | |
| Pubmed | Tissue-specific requirements of beta-catenin in external genitalia development. | 8.86e-11 | 38 | 65 | 6 | 18635608 | |
| Pubmed | Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. | 2.22e-10 | 19 | 65 | 5 | 21623369 | |
| Pubmed | Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. | 3.40e-10 | 47 | 65 | 6 | 28813421 | |
| Pubmed | 3.40e-10 | 47 | 65 | 6 | 18351675 | ||
| Pubmed | 3.40e-10 | 47 | 65 | 6 | 33141892 | ||
| Pubmed | 3.87e-10 | 7 | 65 | 4 | 15195140 | ||
| Pubmed | Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. | 4.42e-10 | 49 | 65 | 6 | 19562671 | |
| Pubmed | 5.01e-10 | 50 | 65 | 6 | 27510977 | ||
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 7.73e-10 | 8 | 65 | 4 | 8163463 | |
| Pubmed | 7.73e-10 | 8 | 65 | 4 | 19388021 | ||
| Pubmed | 8.06e-10 | 24 | 65 | 5 | 9096311 | ||
| Pubmed | 8.06e-10 | 24 | 65 | 5 | 8626800 | ||
| Pubmed | Direct interaction of Frizzled-1, -2, -4, and -7 with PDZ domains of PSD-95. | 1.39e-09 | 9 | 65 | 4 | 12067714 | |
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 9813155 | ||
| Pubmed | Frizzled proteins are colonic epithelial receptors for C. difficile toxin B. | 6.23e-09 | 3 | 65 | 3 | 27680706 | |
| Pubmed | 7.03e-09 | 36 | 65 | 5 | 12412008 | ||
| Pubmed | Integrated analysis of Wnt signalling system component gene expression. | 8.11e-09 | 37 | 65 | 5 | 35831952 | |
| Pubmed | 1.85e-08 | 90 | 65 | 6 | 19515997 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 2.49e-08 | 4 | 65 | 3 | 10469592 | |
| Pubmed | Reelin signaling facilitates maturation of CA1 glutamatergic synapses. | 6.21e-08 | 5 | 65 | 3 | 17229826 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 19543507 | ||
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 25800971 | ||
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 10395542 | ||
| Pubmed | 8.95e-08 | 117 | 65 | 6 | 17145500 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.15e-07 | 24 | 65 | 4 | 35746896 | |
| Pubmed | Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling. | 1.24e-07 | 6 | 65 | 3 | 20802536 | |
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 36867021 | ||
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 20418887 | ||
| Pubmed | 1.24e-07 | 6 | 65 | 3 | 18922769 | ||
| Pubmed | Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. | 2.17e-07 | 7 | 65 | 3 | 9192640 | |
| Pubmed | Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. | 2.17e-07 | 7 | 65 | 3 | 21558424 | |
| Pubmed | Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription. | 2.17e-07 | 7 | 65 | 3 | 11265645 | |
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 15923619 | ||
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 23760271 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 14602821 | ||
| Pubmed | 3.47e-07 | 8 | 65 | 3 | 19643732 | ||
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 23095888 | ||
| Pubmed | A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. | 5.19e-07 | 9 | 65 | 3 | 9160667 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 9.41e-07 | 94 | 65 | 5 | 21542922 | |
| Pubmed | Ephrin-A5 and EphA5 interaction induces synaptogenesis during early hippocampal development. | 1.02e-06 | 11 | 65 | 3 | 20824214 | |
| Pubmed | ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. | 1.02e-06 | 11 | 65 | 3 | 22575959 | |
| Pubmed | 1.56e-06 | 45 | 65 | 4 | 25979088 | ||
| Pubmed | Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders. | 1.76e-06 | 13 | 65 | 3 | 29488136 | |
| Pubmed | 1.76e-06 | 13 | 65 | 3 | 31841517 | ||
| Pubmed | Role of chromatin remodeling gene Cecr2 in neurulation and inner ear development. | 1.76e-06 | 13 | 65 | 3 | 21246654 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 1.76e-06 | 13 | 65 | 3 | 20859245 | |
| Pubmed | 1.76e-06 | 13 | 65 | 3 | 22266179 | ||
| Pubmed | 2.23e-06 | 14 | 65 | 3 | 19240213 | ||
| Pubmed | WNT signaling affects gene expression in the ventral diencephalon and pituitary gland growth. | 2.40e-06 | 50 | 65 | 4 | 18351662 | |
| Pubmed | 2.79e-06 | 15 | 65 | 3 | 15617677 | ||
| Pubmed | Transferrin Receptor Controls AMPA Receptor Trafficking Efficiency and Synaptic Plasticity. | 2.79e-06 | 15 | 65 | 3 | 26880306 | |
| Pubmed | 2.79e-06 | 15 | 65 | 3 | 9481670 | ||
| Pubmed | 3.43e-06 | 16 | 65 | 3 | 30466882 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 25131300 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 37657442 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 38813758 | ||
| Pubmed | Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice. | 3.44e-06 | 2 | 65 | 2 | 30076839 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 30366920 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 28951524 | ||
| Pubmed | Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer's Disease. | 3.44e-06 | 2 | 65 | 2 | 38731978 | |
| Pubmed | Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. | 3.44e-06 | 2 | 65 | 2 | 20921396 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 28754779 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 30269991 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 27199241 | ||
| Pubmed | The role of NMDAR subtypes and charge transfer during hippocampal LTP induction. | 3.44e-06 | 2 | 65 | 2 | 16901514 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 31498792 | ||
| Pubmed | Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis. | 3.44e-06 | 2 | 65 | 2 | 33036922 | |
| Pubmed | Role of major NMDA or AMPA receptor subunits in MK-801 potentiation of ethanol intoxication. | 3.44e-06 | 2 | 65 | 2 | 18565157 | |
| Pubmed | Age-Dependent Changes in Synaptic NMDA Receptor Composition in Adult Human Cortical Neurons. | 3.44e-06 | 2 | 65 | 2 | 32191258 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 20696923 | ||
| Pubmed | Distinct roles of GRIN2A and GRIN2B variants in neurological conditions. | 3.44e-06 | 2 | 65 | 2 | 31807283 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 23618906 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 26500840 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 2565717 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 19474217 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 27015584 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 38493481 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 19806658 | ||
| Pubmed | Importance of the GluN2B carboxy-terminal domain for enhancement of social memories. | 3.44e-06 | 2 | 65 | 2 | 26179233 | |
| Pubmed | Melanocyte stem cells express receptors for canonical Wnt-signaling pathway on their surface. | 3.44e-06 | 2 | 65 | 2 | 20450888 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 22142193 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 33976221 | ||
| Pubmed | Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. | 3.44e-06 | 2 | 65 | 2 | 16033900 | |
| Interaction | DLG2 interactions | 3.94e-09 | 83 | 58 | 7 | int:DLG2 | |
| Interaction | DLG4 interactions | 5.05e-06 | 449 | 58 | 9 | int:DLG4 | |
| Interaction | SCGB1C1 interactions | 6.34e-06 | 13 | 58 | 3 | int:SCGB1C1 | |
| Interaction | CTRB2 interactions | 2.44e-05 | 3 | 58 | 2 | int:CTRB2 | |
| Interaction | WNT5A interactions | 4.64e-05 | 69 | 58 | 4 | int:WNT5A | |
| Interaction | LYPD3 interactions | 5.31e-05 | 141 | 58 | 5 | int:LYPD3 | |
| Interaction | OR1D4 interactions | 5.61e-05 | 26 | 58 | 3 | int:OR1D4 | |
| Interaction | DLG1 interactions | 6.46e-05 | 240 | 58 | 6 | int:DLG1 | |
| Interaction | SLC35B1 interactions | 7.04e-05 | 28 | 58 | 3 | int:SLC35B1 | |
| Interaction | UPK1A interactions | 7.13e-05 | 150 | 58 | 5 | int:UPK1A | |
| Interaction | GRIK2 interactions | 1.06e-04 | 32 | 58 | 3 | int:GRIK2 | |
| Interaction | SLC25A46 interactions | 1.16e-04 | 267 | 58 | 6 | int:SLC25A46 | |
| Interaction | ZNRF3 interactions | 1.39e-04 | 35 | 58 | 3 | int:ZNRF3 | |
| Interaction | GK interactions | 1.49e-04 | 93 | 58 | 4 | int:GK | |
| Interaction | GRIN2A interactions | 1.49e-04 | 93 | 58 | 4 | int:GRIN2A | |
| Interaction | CTRB1 interactions | 1.69e-04 | 7 | 58 | 2 | int:CTRB1 | |
| Cytoband | 14q22.2 | 8.82e-05 | 10 | 65 | 2 | 14q22.2 | |
| Cytoband | 4q23 | 3.69e-04 | 20 | 65 | 2 | 4q23 | |
| Cytoband | 16q23.1 | 9.53e-04 | 32 | 65 | 2 | 16q23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 1.27e-03 | 37 | 65 | 2 | chr4q23 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 8.84e-14 | 11 | 46 | 6 | 286 | |
| GeneFamily | Solute carriers | SLCO1B7 SLC44A1 SLC9A5 SLC28A2 SLC35G2 SLC5A8 SLC9C2 SLC14A2 SLC35F4 | 5.58e-07 | 395 | 46 | 9 | 752 |
| GeneFamily | Glycerol kinases | 9.44e-05 | 6 | 46 | 2 | 568 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.32e-04 | 7 | 46 | 2 | 1201 | |
| GeneFamily | CD molecules|Tetraspanins | 3.18e-03 | 33 | 46 | 2 | 768 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 4.64e-03 | 40 | 46 | 2 | 592 | |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP | 5.30e-06 | 193 | 60 | 6 | M3484 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 1.46e-05 | 135 | 60 | 5 | M5825 | |
| Coexpression | GU_PDEF_TARGETS_UP | 2.15e-05 | 71 | 60 | 4 | M3955 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-06 | 193 | 60 | 5 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-06 | 194 | 60 | 5 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 141 | 60 | 4 | 091b5b72811db5fca2314f4a79d467566920e257 | |
| ToppCell | NS-critical-LOC-Myeloid-Basophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.43e-05 | 160 | 60 | 4 | 8a4746463ca1976f7d6de803496c851249ced797 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-05 | 162 | 60 | 4 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-05 | 162 | 60 | 4 | bfaeff19bb56598fdc8c82be71d51787cf13928f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-05 | 162 | 60 | 4 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-05 | 162 | 60 | 4 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.75e-05 | 162 | 60 | 4 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.25e-05 | 165 | 60 | 4 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.25e-05 | 165 | 60 | 4 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 168 | 60 | 4 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 168 | 60 | 4 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 7.95e-05 | 169 | 60 | 4 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-05 | 170 | 60 | 4 | 833b4f44ea1fa673dfc6b43ce45a79fe68ae3b05 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 8.32e-05 | 171 | 60 | 4 | 0d14bc9688c427ba2265984987dc3eea195b19eb | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 8.70e-05 | 173 | 60 | 4 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 9.30e-05 | 176 | 60 | 4 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.72e-05 | 178 | 60 | 4 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-05 | 178 | 60 | 4 | 5fc9f41609735b972a2cd0830182d13742cd5bf5 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 180 | 60 | 4 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 1.01e-04 | 180 | 60 | 4 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 180 | 60 | 4 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 181 | 60 | 4 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 181 | 60 | 4 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 183 | 60 | 4 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | wk_15-18-Epithelial-PNS-intermediate_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.08e-04 | 183 | 60 | 4 | d874aa9a856f79626c8a8371f6196a77b7d662ee | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 183 | 60 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 184 | 60 | 4 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-04 | 186 | 60 | 4 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 187 | 60 | 4 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 188 | 60 | 4 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 188 | 60 | 4 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | wk_08-11-Epithelial-PNS-intermediate_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.20e-04 | 188 | 60 | 4 | 3f3a744b2615bf72f6119f26087099110c0d21fc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 189 | 60 | 4 | 3e8e30160a8d6f531ff743cb5918c9e79481f1bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 189 | 60 | 4 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 189 | 60 | 4 | 851f8144aed5c7f80302911cd6b03f14bde7b56d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 189 | 60 | 4 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 190 | 60 | 4 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 190 | 60 | 4 | 1c5cf933ce71fed5638b9ef31eb81f6c2b6dadbc | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.25e-04 | 190 | 60 | 4 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 190 | 60 | 4 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 190 | 60 | 4 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 190 | 60 | 4 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.25e-04 | 190 | 60 | 4 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 190 | 60 | 4 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 60 | 4 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 191 | 60 | 4 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 192 | 60 | 4 | fd08ae787e936cfdb1ab8f19b0fd63005b462709 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 192 | 60 | 4 | bae236c9f1fac77bce28d0a9cf090100d391ff77 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-04 | 192 | 60 | 4 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | COVID-19_Convalescent-CD4+_T_naive|COVID-19_Convalescent / Disease condition and Cell class | 1.33e-04 | 193 | 60 | 4 | 346caaf288217acaf232060629ce964a07f63432 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.33e-04 | 193 | 60 | 4 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.33e-04 | 193 | 60 | 4 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 193 | 60 | 4 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 193 | 60 | 4 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.33e-04 | 193 | 60 | 4 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 194 | 60 | 4 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 194 | 60 | 4 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-late_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.35e-04 | 194 | 60 | 4 | 23b06707d21306b4483d64cb350b86aef352ce38 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 195 | 60 | 4 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 195 | 60 | 4 | ba7cb80deb872c9184769f0dd57855c3c6a432bf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 196 | 60 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.41e-04 | 196 | 60 | 4 | 51c48944149a89b98011a50fe81ca6664d5f0d44 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.41e-04 | 196 | 60 | 4 | 2aeb792e7685e33e3543a6974be790980a41ed8c | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.44e-04 | 197 | 60 | 4 | b71da7f2fd8d526fb6e5d57e60fc08acdd8dbefb | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.44e-04 | 197 | 60 | 4 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-04 | 197 | 60 | 4 | 3fe665c0277d091290b63f0dd24c0c6536a45309 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.44e-04 | 197 | 60 | 4 | e567886d69c6ea8dec87019c2ebc593793cb3107 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-04 | 198 | 60 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-04 | 198 | 60 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-04 | 198 | 60 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-04 | 198 | 60 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | COVID-19-COVID-19_Severe-Others-RBC|COVID-19_Severe / Disease, condition lineage and cell class | 1.52e-04 | 200 | 60 | 4 | 308f74e7e13ecc6d133c219c42cc8895a96644c8 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.52e-04 | 200 | 60 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-04 | 200 | 60 | 4 | f692b602bc989d35c9162e73dda813dbef8d5267 | |
| Drug | A 172 | 8.21e-10 | 70 | 62 | 7 | CID000014025 | |
| Drug | aurintricarboxylic acid | 5.30e-09 | 91 | 62 | 7 | CID000002259 | |
| Drug | AC1L9M5J | 8.44e-09 | 221 | 62 | 9 | CID000448615 | |
| Drug | Prestwick_517 | 1.55e-08 | 106 | 62 | 7 | CID000003804 | |
| Drug | 6,7-dinitroquinoxaline | 2.84e-08 | 33 | 62 | 5 | CID002724608 | |
| Drug | kainite | 3.87e-08 | 35 | 62 | 5 | CID000164810 | |
| Drug | 2-amino-3-phosphonopropionic acid | 6.00e-08 | 76 | 62 | 6 | CID000003857 | |
| Drug | argiopine | 8.85e-08 | 16 | 62 | 4 | CID000122294 | |
| Drug | IDRA 21 | 2.34e-07 | 20 | 62 | 4 | CID000003688 | |
| Drug | NS 102 | 3.51e-07 | 22 | 62 | 4 | CID005282252 | |
| Drug | CX516 | 3.51e-07 | 22 | 62 | 4 | CID000148184 | |
| Drug | dimethyloxalylglycine; Up 200; 1000uM; PC3; HG-U133A | 4.31e-07 | 172 | 62 | 7 | 584_UP | |
| Drug | GYKI 52466 | 5.21e-07 | 58 | 62 | 5 | CID000003538 | |
| Drug | ifenprodil | 1.07e-06 | 8 | 62 | 3 | ctd:C010739 | |
| Drug | perzinfotel | 1.07e-06 | 8 | 62 | 3 | CID006918236 | |
| Drug | AC1NUW3V | 1.12e-06 | 29 | 62 | 4 | CID005462126 | |
| Drug | L-Glutamic Acid | 1.16e-06 | 68 | 62 | 5 | DB00142 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 1.30e-06 | 30 | 62 | 4 | CID000001226 | |
| Drug | LY293558 | 1.30e-06 | 30 | 62 | 4 | CID000127894 | |
| Drug | 4-methylglutamic acid | 1.48e-06 | 31 | 62 | 4 | CID000005365 | |
| Drug | AC1L1DME | 1.89e-06 | 75 | 62 | 5 | CID000002414 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 1.92e-06 | 33 | 62 | 4 | CID000002071 | |
| Drug | clofazimine | 2.45e-06 | 35 | 62 | 4 | CID000002794 | |
| Drug | R,S)-AMPA | 2.75e-06 | 36 | 62 | 4 | CID000001221 | |
| Drug | pilocarpine- | 2.98e-06 | 147 | 62 | 6 | CID000004819 | |
| Drug | gamma-Glu-Gly | 3.08e-06 | 37 | 62 | 4 | CID000100099 | |
| Drug | D-N-Q | 3.32e-06 | 84 | 62 | 5 | CID000003140 | |
| Drug | CGS 19755 | 3.43e-06 | 38 | 62 | 4 | CID000068736 | |
| Drug | GAMs | 3.43e-06 | 38 | 62 | 4 | CID000002935 | |
| Drug | L-BMAA | 3.43e-06 | 38 | 62 | 4 | CID000028558 | |
| Drug | Dieldrin | ADH5 FZD1 FZD7 FZD8 SLC44A1 CGRRF1 APAF1 GRIA1 GRIK3 GRIN2B HERC2 COQ2 FZD2 KYAT1 | 3.76e-06 | 1217 | 62 | 14 | ctd:D004026 |
| Drug | DETC-MeSO | 3.82e-06 | 39 | 62 | 4 | CID003035711 | |
| Drug | HA-966 | 3.82e-06 | 39 | 62 | 4 | CID000001232 | |
| Drug | LY341495 | 5.68e-06 | 43 | 62 | 4 | CID006324636 | |
| Drug | Joro spider toxin | 5.68e-06 | 43 | 62 | 4 | CID000119582 | |
| Drug | philanthotoxin | 6.83e-06 | 45 | 62 | 4 | CID000115201 | |
| Drug | 7-chlorokynurenic acid | 6.83e-06 | 45 | 62 | 4 | CID000001884 | |
| Drug | c189 | 7.30e-06 | 2 | 62 | 2 | CID000248048 | |
| Drug | BOCPheONP | 7.30e-06 | 2 | 62 | 2 | CID000111308 | |
| Drug | dansyl-D-arginine methyl ester | 7.30e-06 | 2 | 62 | 2 | CID000191369 | |
| Drug | MPM-06 | 7.30e-06 | 2 | 62 | 2 | CID000161546 | |
| Drug | methyl 6-phenylhexanoate | 7.30e-06 | 2 | 62 | 2 | CID011820300 | |
| Drug | NSC-374899 | 7.30e-06 | 2 | 62 | 2 | CID000435726 | |
| Drug | 5-aminotetrazole | 7.30e-06 | 2 | 62 | 2 | CID000020467 | |
| Drug | 2-bromoisobutyric acid | 7.30e-06 | 2 | 62 | 2 | CID000074924 | |
| Drug | p-toluamidine | 7.30e-06 | 2 | 62 | 2 | CID000122753 | |
| Drug | methylbenzenebutanoate | 7.30e-06 | 2 | 62 | 2 | CID000281254 | |
| Drug | N-acetyl-alpha-azaphenylalanine phenyl ester | 7.30e-06 | 2 | 62 | 2 | CID000191275 | |
| Drug | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | 7.30e-06 | 2 | 62 | 2 | CID004418081 | |
| Drug | isobutyl sulfide | 7.30e-06 | 2 | 62 | 2 | CID000011607 | |
| Drug | thiokynurenic acid | 8.55e-06 | 15 | 62 | 3 | CID003035667 | |
| Drug | ACEA-1011 | 8.55e-06 | 15 | 62 | 3 | CID000127872 | |
| Drug | Chlorpyrifos | FZD1 FZD7 CLCN3 TENM3 CGRRF1 FZD5 APAF1 GRIA1 GRIK3 GRIN2A GRIN2B CTRB1 | 9.08e-06 | 960 | 62 | 12 | ctd:D004390 |
| Drug | methylenecyclopropylglycine | 9.63e-06 | 49 | 62 | 4 | CID000441452 | |
| Drug | 5,7-dichlorokynurenic acid | 9.63e-06 | 49 | 62 | 4 | CID000001779 | |
| Drug | AC1L1FA8 | 1.05e-05 | 50 | 62 | 4 | CID000003150 | |
| Drug | LY233536 | 1.05e-05 | 16 | 62 | 3 | CID000126239 | |
| Drug | aspartate | 1.06e-05 | 518 | 62 | 9 | CID000000424 | |
| Drug | LY354740 | 1.13e-05 | 51 | 62 | 4 | CID000114827 | |
| Drug | kynurenine | 1.14e-05 | 108 | 62 | 5 | CID000000846 | |
| Drug | Quinoxaline | 1.22e-05 | 52 | 62 | 4 | CID000007045 | |
| Drug | AC1L1EKQ | 1.22e-05 | 52 | 62 | 4 | CID000002834 | |
| Drug | 7-Cl-Thio-Kyna | 1.27e-05 | 17 | 62 | 3 | CID003035668 | |
| Drug | kazinol B | 1.27e-05 | 17 | 62 | 3 | CID000480869 | |
| Drug | Kainic Acid | 1.46e-05 | 194 | 62 | 6 | ctd:D007608 | |
| Drug | MNQX | 1.52e-05 | 18 | 62 | 3 | CID000130818 | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A | 1.69e-05 | 199 | 62 | 6 | 4334_UP | |
| Drug | DL-Serine | 1.89e-05 | 203 | 62 | 6 | CID000000617 | |
| Drug | MPEP | 2.03e-05 | 59 | 62 | 4 | CID003025961 | |
| Drug | ibotenic acid | 2.06e-05 | 122 | 62 | 5 | CID000001233 | |
| Drug | kynurenic acid | 2.06e-05 | 122 | 62 | 5 | CID000003845 | |
| Drug | 3-amino-2-pyridone | 2.18e-05 | 3 | 62 | 2 | CID000322353 | |
| Drug | ASA-BMPA | 2.18e-05 | 3 | 62 | 2 | CID003035649 | |
| Drug | p-nitrophenyl benzoate | 2.18e-05 | 3 | 62 | 2 | CID000070396 | |
| Drug | N-acetylbenzotriazole | 2.18e-05 | 3 | 62 | 2 | CID000087784 | |
| Drug | Z-Phe-OMe | 2.18e-05 | 3 | 62 | 2 | CID003082435 | |
| Drug | photophor | 2.18e-05 | 3 | 62 | 2 | CID000014780 | |
| Drug | 3-methylcoumarin | 2.18e-05 | 3 | 62 | 2 | CID000017130 | |
| Drug | dibutyl iodomethaneboronate | 2.18e-05 | 3 | 62 | 2 | CID000098591 | |
| Drug | zinc;dipicolinate | 2.18e-05 | 3 | 62 | 2 | CID004309911 | |
| Drug | 2-propyl methylphosphonochloridate | 2.18e-05 | 3 | 62 | 2 | CID000102124 | |
| Drug | 2-oxobut-3-ynoate | 2.18e-05 | 3 | 62 | 2 | CID000171547 | |
| Drug | AFMeq | 2.18e-05 | 3 | 62 | 2 | CID000194069 | |
| Drug | Bz-Cti-otbu | 2.18e-05 | 3 | 62 | 2 | CID006452691 | |
| Drug | n-(2-oxoethyl)benzamide | 2.18e-05 | 3 | 62 | 2 | CID000188995 | |
| Drug | AC1L49DM | 2.18e-05 | 3 | 62 | 2 | CID000152933 | |
| Drug | FK-316 | 2.18e-05 | 3 | 62 | 2 | CID000133688 | |
| Drug | AC1L19T8 | 2.18e-05 | 3 | 62 | 2 | CID000000694 | |
| Drug | Marinostatin D | 2.18e-05 | 3 | 62 | 2 | CID000132206 | |
| Drug | c140 | 2.18e-05 | 3 | 62 | 2 | CID002783250 | |
| Drug | conotoxin GV | 2.18e-05 | 3 | 62 | 2 | ctd:C055407 | |
| Drug | 1FD7 | 2.18e-05 | 3 | 62 | 2 | CID000445579 | |
| Drug | Benzamidomethaneboronic acid | 2.18e-05 | 3 | 62 | 2 | CID000127677 | |
| Drug | Felbamate | 2.18e-05 | 3 | 62 | 2 | DB00949 | |
| Drug | phenyl hippurate | 2.18e-05 | 3 | 62 | 2 | CID000076323 | |
| Drug | FK-386 | 2.18e-05 | 3 | 62 | 2 | CID000135044 | |
| Drug | FK-375 | 2.18e-05 | 3 | 62 | 2 | CID000135042 | |
| Drug | carbostyril-124 | 2.18e-05 | 3 | 62 | 2 | CID000088277 | |
| Drug | N-trifluoroacetyl-4-fluorophenylalanine | 2.18e-05 | 3 | 62 | 2 | CID000328214 | |
| Drug | Glt-leu-phe-nh-meq | 2.18e-05 | 3 | 62 | 2 | CID000194914 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 1.37e-06 | 11 | 61 | 3 | DOID:9279 (implicated_via_orthology) | |
| Disease | level of chymotrypsinogen B2 in blood serum | 4.20e-06 | 2 | 61 | 2 | OBA_2041192 | |
| Disease | chymotrypsinogen B measurement | 1.26e-05 | 3 | 61 | 2 | EFO_0801477 | |
| Disease | glycerol kinase deficiency (implicated_via_orthology) | 1.26e-05 | 3 | 61 | 2 | DOID:0060363 (implicated_via_orthology) | |
| Disease | Morphine Abuse | 8.77e-05 | 7 | 61 | 2 | C0600272 | |
| Disease | Morphine Dependence | 8.77e-05 | 7 | 61 | 2 | C0026552 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 1.17e-04 | 8 | 61 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 1.17e-04 | 8 | 61 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | Asthma, Occupational | 1.87e-04 | 10 | 61 | 2 | C0264423 | |
| Disease | vascular dementia (is_marker_for) | 2.28e-04 | 11 | 61 | 2 | DOID:8725 (is_marker_for) | |
| Disease | trypsin-2 measurement | 2.28e-04 | 11 | 61 | 2 | EFO_0008305 | |
| Disease | schizophrenia (biomarker_via_orthology) | 4.34e-04 | 15 | 61 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | Acute myeloid leukemia | 5.60e-04 | 17 | 61 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 5.60e-04 | 17 | 61 | 2 | 601626 | |
| Disease | epilepsy (biomarker_via_orthology) | 8.61e-04 | 21 | 61 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | HbA1c measurement, response to sulfonylurea | 8.61e-04 | 21 | 61 | 2 | EFO_0004541, EFO_0007922 | |
| Disease | Huntington's disease (is_implicated_in) | 1.03e-03 | 23 | 61 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 1.13e-03 | 24 | 61 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | status epilepticus (biomarker_via_orthology) | 1.18e-03 | 100 | 61 | 3 | DOID:1824 (biomarker_via_orthology) | |
| Disease | diet measurement | 1.38e-03 | 1049 | 61 | 8 | EFO_0008111 | |
| Disease | bipolar disorder (is_implicated_in) | 1.65e-03 | 29 | 61 | 2 | DOID:3312 (is_implicated_in) | |
| Disease | Mental Depression | 1.90e-03 | 254 | 61 | 4 | C0011570 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WSFDGTVKVWNIITG | 1061 | O14727 | |
| KDGAWTLVGIVSWGS | 221 | Q6GPI1 | |
| GLWVWVSLLVAAGTV | 6 | Q15303 | |
| GIGELVWGKLRGFSW | 291 | Q9Y6K1 | |
| GRTWKGTAFGGWKSV | 311 | P11766 | |
| GKLLATGIQWGTWTK | 351 | Q86XS5 | |
| GSLALGAVPTWTKLW | 51 | Q8TBR5 | |
| KWSFGTTLWEICSGG | 736 | O60674 | |
| IVGGVIWKTIGWKLL | 601 | Q8IWA4 | |
| LTFNWGALLGWSAIK | 211 | Q96H96 | |
| GTIDSWLIWSLTGGV | 176 | Q14409 | |
| FSLALTKSGVVWTWG | 3216 | O95714 | |
| LVWKGQSSWGTGESF | 546 | Q03252 | |
| ALWWGTITLTTIGYG | 301 | Q9NR82 | |
| RWSSVFWKVGLISGT | 56 | Q8IZ57 | |
| VGITSGFWIWSGKTL | 531 | Q14332 | |
| KTWEIGKVITWGRGF | 821 | P63132 | |
| WWSLGVLLFSLATGK | 286 | Q96LW2 | |
| KTWEIGKVITWGRGF | 821 | P63135 | |
| KTWEIGKVITWGRGF | 821 | Q9BXR3 | |
| LIVGITSGFWIWSGK | 611 | Q9UP38 | |
| LVGITSGMWIWSAKT | 486 | Q9ULV1 | |
| LVVGITSGVWIWSGK | 511 | Q13467 | |
| GITTGFWIWSGKTLQ | 541 | O75084 | |
| VGITSGVWVWSGKTL | 596 | Q9H461 | |
| IPWKWLFGATAVALG | 386 | Q14318 | |
| GTIDSWLIWSLTGGV | 176 | Q14410 | |
| WLKGLTQAFGGFLIW | 411 | O15228 | |
| SSWISWGVGVFLLKP | 116 | Q8WUX9 | |
| WIAGGTWTPSALKFA | 696 | P12110 | |
| AFTVEKLTGSGELWW | 226 | P01730 | |
| GTIDSWLIWSLTGGV | 176 | P32189 | |
| IPKGVVSFKSGNWGW | 301 | Q9NR34 | |
| WGLVQWTKSGLALGG | 51 | Q6UWL6 | |
| GSLGGTGVLWWLYAK | 251 | Q8WWI5 | |
| SGRIVGGVWWFFTLI | 611 | P42261 | |
| KALSTRIIGGIWWFF | 631 | Q13003 | |
| IVTTGLVLGWFGWDV | 26 | Q99675 | |
| VGKWPWQVSILFLGT | 51 | E5RG02 | |
| GWGFSGWISALVVPK | 256 | O14828 | |
| KDGAWTLVGIVSWGS | 221 | P17538 | |
| TFSVTGWKLGWSIGP | 281 | Q6YP21 | |
| KGSDVWSFGVLLWEL | 301 | Q16584 | |
| GLIWWVTGTASAAGL | 261 | Q9H720 | |
| SLSIWGWGSLGIVLF | 6 | Q9Y5W8 | |
| TALFTFGWTGTIWGI | 286 | Q8TBE7 | |
| FGWTGTIWGISTMFI | 291 | Q8TBE7 | |
| GKTFSATGWKVGWVL | 246 | Q16773 | |
| KWAWDSGLVLGTLIF | 356 | Q14940 | |
| TFWTIIIGGTFTWTS | 241 | Q8N695 | |
| WWLGFLVSGIVSIIS | 211 | G3V0H7 | |
| WGLLIILSVSSSWVG | 166 | A4IF30 | |
| WTKWVFAGVSLVGLI | 146 | O43868 | |
| WSGWLVVTLTGLASG | 126 | P51790 | |
| WVGGLILWLSVGSSG | 11 | Q53H76 | |
| NILSGASWVSWGLVK | 426 | Q8N0X7 | |
| ASWVSWGLVKGAEIT | 431 | Q8N0X7 | |
| WLKVGFTLGTTVFLW | 41 | O43677 | |
| KTWEIGKVITWGRGF | 821 | P10266 | |
| KTWEIGKVITWGRGF | 821 | P63133 | |
| VSLLGTWIGKGTERW | 1041 | Q9C0C9 | |
| KTWEIGKVITWGRGF | 821 | Q9UQG0 | |
| GGAQSWLWFATVKSL | 2481 | Q9P273 | |
| WLWFATVKSLIGKGV | 2486 | Q9P273 | |
| ITFLGIGLWAWNEKG | 31 | P62079 | |
| WGVVITWSGIKGVFN | 371 | Q5TAH2 | |
| TWSGIKGVFNLLWAP | 376 | Q5TAH2 | |
| VVFLGVGLWAWSEKG | 31 | Q8NG11 | |
| WWTITGGLGTVVSTL | 151 | Q15849 | |
| GPSFTIGKAIWLLWG | 596 | Q12879 | |
| GGPSFTIGKAIWLLW | 596 | Q13224 |